Nodal recurrence | Age | Stage | Grade | LVSI | HIR | Nodal assessment | Adjuvant therapy | Nodal recurrence | Concurrent recurrence sites |
---|---|---|---|---|---|---|---|---|---|
I | 57 | 1B | 2 | Present | Y | Pelvic | Vaginal brachytherapy | Pelvic | – |
II | 61 | 1A | 2 | Absent | N | Pelvic | Megestrol acetate | Pelvic | Lungs |
III | 54 | 1A | 1 | Absent | N | Pelvic | None | Pelvic | Vaginal vault |
IV | 72 | 1B | 3 | Present | Y | Pelvic and PA | Pelvic EBRT | Pelvic, para-aortic | – |
V | 65 | 1A | 3 | Present | Y | Pelvic and PA | None | Pelvic | Vaginal vault, bone |
VI | 52 | 1B | 2 | Present | Y | Pelvic | None | Pelvic | – |
VII | 64 | 1B | 2 | Present | Y | Pelvic | None | Pelvic | Vaginal vault |
VIII | 77 | 1B | 3 | Present | Y | Pelvic and PA | Vaginal brachytherapy | Pelvic | Abdomen |
IX | 67 | 1B | 3 | Present | Y | Pelvic | Pelvic EBRT | Mediastinum | – |
X | 70 | 1A | 3 | Present | Y | Pelvic | Pelvic EBRT | Mediastinum | Brain |
XI | 65 | 1A | 3 | Present | Y | Pelvic and PA | Chemotherapy | Para-aortic | Abdomen |